APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 263 filers reported holding APELLIS PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $48,964 | -66.1% | 1,276,426 | -48.1% | 0.01% | -66.7% |
Q1 2024 | $144,556 | -1.8% | 2,459,246 | -0.0% | 0.02% | -10.0% |
Q4 2023 | $147,277 | +117.1% | 2,460,339 | +38.0% | 0.02% | +100.0% |
Q3 2023 | $67,836 | -89.5% | 1,783,241 | -74.8% | 0.01% | -88.9% |
Q2 2023 | $644,280 | +112.8% | 7,072,226 | +54.1% | 0.09% | +100.0% |
Q1 2023 | $302,760 | +112.9% | 4,590,040 | +66.9% | 0.04% | +95.7% |
Q4 2022 | $142,179 | -99.9% | 2,749,542 | -17.9% | 0.02% | -37.8% |
Q3 2022 | $228,871,000 | -41.7% | 3,350,963 | -61.4% | 0.04% | -26.0% |
Q2 2022 | $392,501,000 | -2.0% | 8,679,813 | +10.1% | 0.05% | +25.0% |
Q1 2022 | $400,629,000 | +59.9% | 7,884,839 | +48.8% | 0.04% | +73.9% |
Q4 2021 | $250,513,000 | +58.1% | 5,298,491 | +10.2% | 0.02% | +53.3% |
Q3 2021 | $158,441,000 | -51.5% | 4,807,077 | -7.0% | 0.02% | -50.0% |
Q2 2021 | $326,775,000 | +109.1% | 5,170,494 | +42.0% | 0.03% | +87.5% |
Q1 2021 | $156,285,000 | -10.3% | 3,642,149 | +19.6% | 0.02% | -11.1% |
Q4 2020 | $174,193,000 | +93.9% | 3,045,329 | +2.2% | 0.02% | +80.0% |
Q3 2020 | $89,858,000 | -9.1% | 2,978,400 | -1.6% | 0.01% | -16.7% |
Q2 2020 | $98,889,000 | +195.1% | 3,027,835 | +142.1% | 0.01% | +140.0% |
Q1 2020 | $33,511,000 | +38.2% | 1,250,870 | +58.0% | 0.01% | +66.7% |
Q4 2019 | $24,241,000 | +15.1% | 791,663 | -9.5% | 0.00% | 0.0% |
Q3 2019 | $21,065,000 | +18.9% | 874,412 | +25.1% | 0.00% | +50.0% |
Q2 2019 | $17,718,000 | +33.6% | 699,212 | +2.8% | 0.00% | 0.0% |
Q1 2019 | $13,258,000 | +39.8% | 679,888 | -5.4% | 0.00% | 0.0% |
Q4 2018 | $9,482,000 | -41.4% | 718,883 | -21.1% | 0.00% | 0.0% |
Q3 2018 | $16,190,000 | -23.5% | 910,559 | -5.3% | 0.00% | -33.3% |
Q2 2018 | $21,157,000 | – | 961,683 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |